RNAZ - Balance Sheet - TransCode Therapeutics, Inc.

Current Liabilities	2.77 M
Accounts Payable	0
Short-Term Debt	38.3 K
Other Current Liabilities	2.73 M
Non-Current Liabilities	6.54 M
Long-Term Debt	0
Other Non-Current Liabilities	6.54 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	5.8	2.8	5.0	20.8	0.8	0.2	0.2
Short Term Investments	0	0	9.41	9.41	3.2	0	0
Receivables	0	0	0.4	0	0	0	0
Inventory	0	0	0.6	0	0	0	0
Other Current Assets	1.3	1.7	2.1	1.9	3.2 K	0	1.67 K
Total Current Assets	7.1	4.5	7.4	22.7	0.8	0.2	0.2
PP&E	89.3 K	0.6	0.2	0.2	0	0	0
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	12.8 K	12.3 K	0
Other Long Term Assets	0.1	0.1	0	0	0.2	1	0
Other Assets	0	0	0	0	0	12.3 K	0
Total Assets	7.3	5.2	7.6	22.9	1.1	0.2	0.2
LIABILITIES
Accounts Payable	0	0	4.3	2.0	0	0	0
Short Term Debt	38.3 K	0.4	0	0	0	0	35.7 K
Other Current Liabilities	2.7	3.1	0	0.5	0.4	62.9 K	82 K
Total Current Liabilities	2.8	3.5	4.3	2.5	0.4	62.9 K	0.1
Long Term Debt	0	38.3 K	0	0	2.1	0.9	0.4
Deferred Tax Income	0	0	0	0	0	0	0
Other Liabilities	6.5	0	0	0	2.0	0.3	0.2
Total Liabilities	9.3	3.5	4.3	2.5	4.5	1.3	0.7
EQUITY
Common Stock	103	63	1.3 K	1.29 K	464	464	764
Retained Earnings	(63.2)	(46.4)	(27.9)	(10.3)	(3.5)	(1.1)	(0.5)
Other Accumulative Comprehensive Income/Loss	0	0	0	0	12.8	12.3	11.8 K
Total Equity	(2.0)	1.6	3.2	20.4	(3.4)	(1.1)	(0.5)
Total Liabilities and Equity	7.3	5.2	7.6	22.9	1.1	0.2	0.2
SHARES OUTSTANDING
Common Shares Outstanding	0.4	5.37 K	16.2 K	10.5 K	7.98 K	6.41 K	192

Free